Emerging US medical gloves industry fits ‘made-in-America’ plan to cut reliance on global supply chains
- Dire memories of supply shortfalls early in coronavirus pandemic spur home-grown production boosted by government help
- Job creation another goal as nation strives to prepare for next healthcare challenges

Like countless steel mills across the US, the one perched at Sparrows Point, Maryland met an ignominious end after a run of manufacturing glory dating to the 19th century, its furnaces demolished in 2014. But eight years on, a global pandemic has breathed new life into the abandoned site overlooking the Patapsco River outside Baltimore.
No longer a relic of the past but instead a vital piece of an ambitious plan to ensure that the US healthcare system is “made in America”, the vast 700,000-square-foot facility is expected to churn out a staggering 350 million disposable medical-grade nitrile gloves each month and create more than 2,000 jobs by early next year.

Dan Izhaky, the company’s CEO, has billed himself on social media as “passionate about reshoring manufacturing back to the USA” and claimed he is “building the largest nitrile glove factory” in the country.
Largely used to handle chemicals in laboratories and carry out surgical procedures, gloves made of nitrile, a form of rubber, gained commercial prominence over widely used latex gloves during the pandemic. Nitrile gloves help reduce the odds of transmitting infection and are less likely to trigger allergic reactions than other gloves.